Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 15:2021:3718255.
doi: 10.1155/2021/3718255. eCollection 2021.

Efficacy of Bifidobacterium Triple Viable Enteric-Coated Capsules Combined with Enteral Nutrition on Patients with Chronic Critical Illness and Influence on Immune and Coagulation Function

Wei Wang  1 , Hui Zhang  2 , Wenjuan Huang  1
Affiliations

Efficacy of Bifidobacterium Triple Viable Enteric-Coated Capsules Combined with Enteral Nutrition on Patients with Chronic Critical Illness and Influence on Immune and Coagulation Function

Wei Wang et al. Evid Based Complement Alternat Med. .

Retraction in

Abstract

Objective: To investigate the efficacy of enteric-coated Bifidobacterium triple viable capsules combined with enteral nutrition in the treatment of patients with chronic critical illness (CCI) and their effects on the immune and coagulation function of patients.

Methods: 106 CCI patients admitted to the intensive care unit of our hospital from December 2018 to March 2020 were selected as the research objects, and they were randomly divided into the control group (n = 53) and the observation group (n = 53). The control group was given symptomatic treatment, etiological treatment, clinical nursing, enteral nutrition support, and other conventional treatment methods according to the patient's condition. On this basis, the observation group was treated with enteric-coated Bifidobacterium triple viable capsules, and both groups were treated for 14 days. All patients were followed up for 3 months after treatment, and their death/cure prognosis was recorded. The acute physiological and chronic health (APACHE II) scoring system was used to evaluate the acute physiological and chronic health status of the two groups before and after treatment, and the organs of the patients were scored with sepsis-related organ failure assessment (SOFA) score. T lymphocyte subsets (CD3+, CD4+, CD8+, and CD4+/CD8+), prothrombin time (PT), activated partial thrombin time (APTT), fibrinogen (FIB), and D-dimer (DD) were measured before and after treatment.

Results: The cure rate of the observation group was slightly higher than that of the control group, and the mortality rate was slightly lower than that of the control group, but the difference was not statistically significant (P < 0.05). After treatment, the APACHE II and SOFA scores of the two groups were lower than before treatment, and the APACHE II and SOFA scores of the observation group were lower than those of the control group, and the differences were both statistically significant (P < 0.05). After treatment, the levels of CD3+, CD4+, and CD4+/CD8+ in the two groups were higher than those before treatment, and the levels of CD8+ were lower than before treatment. The CD3+, CD4+, and CD4+/CD8+ levels of the observation group were higher than those of the control group, and the CD8+ levels were lower than the control group, and the differences were both statistically significant (P < 0.05). After treatment, the PT and APTT levels of the two groups of patients were higher than those before treatment, and the levels of FIB and DD were lower than those before treatment. The PT and APTT levels of the observation group were higher than those of the control group, and the FIB and DD levels were lower than those of the control group, and the differences were both statistically significant (P < 0.05).

Conclusion: The combination of enteric-coated Bifidobacterium triple viable capsules and enteral nutrition for CCI has high cure rate, which can not only improve the patients' physiological health status and organ dysfunction but also effectively improve the patients' immune and coagulation function, which is worthy of promotion.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Comparison of the immune function of the two groups of patients. Note: compared with before treatment, ∗P < 0.05; compared with the control group, #P < 0.05.
Figure 2
Figure 2
Comparison of the coagulation function of the two groups of patients. Note: compared with before treatment, ∗P < 0.05; compared with the control group, #P < 0.05.
Figure 3
Figure 3
Comparison of nutritional status between the two groups. Note: compared with before treatment, ∗P < 0.05; compared with the control group, #P < 0.05.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Moron R., Galvez J., Colmenero M., Anderson P., Cabeza J., Rodriguez-Cabezas M. E. The importance of the microbiome in critically ill patients: role of nutrition. Nutrients . 2019;11(12):3002–3012. doi: 10.3390/nu11123002. - DOI - PMC - PubMed
    1. Wernerman J., Christopher K. B., Annane D., et al. Metabolic support in the critically ill: a consensus of 19. Critical Care . 2019;23(1):318–327. doi: 10.1186/s13054-019-2597-0. - DOI - PMC - PubMed
    1. Efron P. A., Mohr A. M., Bihorac A., et al. Persistent inflammation, immunosuppression, and catabolism and the development of chronic critical illness after surgery. Surgery . 2018;164(2):178–184. doi: 10.1016/j.surg.2018.04.011. - DOI - PMC - PubMed
    1. Aguiar F. P., Westphal G. A., Dadam M. M., Mota E. C. C, Pfutzenreuter F, França P. H. C. Characteristics and predictors of chronic critical illness in the intensive care unit. Revista Brasileira de terapia intensiva . 2019;31(4):511–520. doi: 10.5935/0103-507X.20190088. - DOI - PMC - PubMed
    1. Dickson R. P. The microbiome and critical illness. The Lancet Respiratory Medicine . 2016;4(1):59–72. doi: 10.1016/s2213-2600(15)00427-0. - DOI - PMC - PubMed

Publication types